Author:
Nishiyama Takashi,Kobayashi Tominari,Jirintai Suljid,Nagashima Shigeo,Primadharsini Putu Prathiwi,Nishizawa Tsutomu,Okamoto Hiroaki
Funder
Japan Agency for Medical Research and Development
AMED
Reference50 articles.
1. The discovery of IDX21437: design, synthesis and antiviral evaluation of 2’-α-chloro-2’-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors;Alexandre;Bioorg. Med. Chem. Lett,2017
2. Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin;Biliotti;Infection,2018
3. Design, synthesis, and antiviral activity of 2’-deoxy-2’-fluoro-2’-C-methylcytidine, a potent inhibitor of hepatitis C virus replication;Clark;J. Med. Chem.,2005
4. Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2’-C-methylcytidine, the active component of valopicitabine;Coelmont;Antimicrob. Agents Chemother.,2006
5. Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin;Dao Thi;Gastroenterology,2016
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献